Alpha Cognition Inc. (ACOG) Current Ratio
- Current ratio · latest quarter: Value 9.03×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 9.03× | Current assets / current liabilities. $57.93M ÷ $6.41M ≈ 9.03× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 57.93M USD | Assets, Current |
| Current obligations | 6.41M USD | Liabilities, Current |
| Cash and equivalents | 41.38M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 5.47M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 6.39M USD | Inventory, Net |
| Payables | 1.19M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $57.93M | $6.41M | $41.38M | (m) | $5.47M | $6.39M | $1.19M | (m) | 9.03× |
| 2026-03-31 | $68.56M | $5.43M | $54.25M | (m) | $3.58M | $6.04M | $1.43M | (m) | 12.64× |
| 2025-12-31 | $79.01M | $9.13M | $66.05M | (m) | $4.24M | $5.12M | $3.07M | (m) | 8.65× |
| 2025-09-30 | $45.70M | $6.83M | $35.40M | (m) | $2.85M | $4.50M | $838.01K | (m) | 6.69× |
| 2025-06-30 | $44.65M | $3.04M | $39.41M | (m) | $1.81M | $875.85K | $752.33K | (m) | 14.69× |
| 2025-03-31 | $48.12M | $2.81M | $45.53M | (m) | $422.80K | $883.38K | $821.87K | (m) | 17.14× |
| 2024-12-31 | $50.25M | $3.35M | $48.55M | (m) | (m) | $615.13K | $872.68K | (m) | 15.00× |
| 2024-09-30 | $4.51M | $3.01M | $3.67M | (m) | (m) | (m) | $790.31K | (m) | 1.50× |
| 2024-06-30 | $1.51M | $1.57M | $1.02M | (m) | (m) | (m) | $484.21K | (m) | 0.96× |
| 2023-12-31 | $1.92M | $2.62M | $1.40M | (m) | (m) | (m) | $475.55K | (m) | 0.73× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |